Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer

dc.contributor.author	Calvo Martínez, Lourdes
dc.date.accessioned	2017-06-07T07:07:50Z
dc.date.available	2017-06-07T07:07:50Z
dc.date.issued	2011
dc.identifier.issn	0959-4973
dc.identifier.uri	http://hdl.handle.net/20.500.11940/2927
dc.language.iso	eng
dc.title	Phase I/II study of biweekly vinorelbine and oxaliplatin as first-line treatment in patients with metastatic breast cancer
dc.type	Artigo	es
dc.authorsophos	Guerrero, A.
dc.authorsophos	Servitja, S.
dc.authorsophos	Rodríguez-Lescure, A.
dc.authorsophos	Calvo, L.
dc.authorsophos	Del Barco, S.
dc.authorsophos	Quintanar, M. T.
dc.authorsophos	Juárez, J. I.
dc.authorsophos	Gayo, J.
dc.authorsophos	Llombart, A.
dc.authorsophos	Tusquets, I.
dc.identifier.isi	286805700011
dc.identifier.pmid	21150776
dc.identifier.sophos	9198
dc.issue.number	3
dc.journal.title	ANTI-CANCER DRUGS
dc.organization	Servizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de A Coruña - Complexo Hospitalario Universitario A Coruña::Oncoloxía médica
dc.page.initial	283
dc.page.final	289
dc.rights.accessRights	openAccess
dc.typesophos	Artículo Original
dc.volume.number	22

Files in this item

Files	Size	Format	View
There are no files associated with this item.